8 Stocks on Jim Cramer's Radar
Jim Cramer, the host of Mad Money, recently shared some investment guidelines based on his 40 years of experience.
Altimmune Inc. (ALT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 0 | $0 | -100% | 0% |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.88 | 300 | Director | 29,785 | 2023-08-15 | Filing | |
| $4.27 | 9,000 | Director | 29,484 | 2023-03-23 | Filing | |
| $4.31 | 10,000 | Officer | 22,010 | 2023-03-24 | Filing | |
| $4.22 | 10,000 | Officer | 33,311 | 2023-03-23 | Filing | |
| $8.00 | 1,000 | Director | 20,012 | 2022-06-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.88 | 8,184 | Director | 55,524 | 2024-08-19 | Filing | |
| $6.93 | 7,827 | Director | 41,958 | 2024-08-19 | Filing | |
| $15.00 | 2,714 | Director | 2,771 | 2022-08-12 | Filing | |
| $15.01 | 20,000 | Director | 8,498 | 2022-12-22 | Filing | |
| $20.02 | 20,000 | Officer, Director | 236,797 | 2022-08-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
11 Reddit Stocks with Biggest Upside Potential
Paul Hickey, Bespoke co-founder, together with Dana D'Auria, Envestnet co-chief Investment Officer, joined CNBC's 'Closing Bell: Overtime' on November 12 to discuss the market's reaction to the election...
Altimmune, Inc. (NASDAQ:ALT) Q3 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Altimmune, Inc. Third Quarter 2024 Financial Results Conference Call. At this time all participants’ are in a listen-only mode.
Altimmune, Inc. (ALT): A Bull Case Theory
We came across a bullish thesis on Altimmune, Inc. (ALT) on WallStreetBets subreddit page by Old-Pomegranate3634. In this article, we will summarize the bulls’ thesis on ALT.
Altimmune, Inc. (NASDAQ:ALT) Q1 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen and welcome to Altimmune Inc. First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Altimmune, Inc. (NASDAQ:ALT) Q4 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Altimmune Inc. Full Year and Fourth Quarter 2023 Financial Results Conference Call.
16 Most Promising Long-Term Stocks According to Analysts
In this piece, we will take a look at the 16 most promising long-term stocks according to analysts.
13 Hot Penny Stocks To Buy According to Hedge Funds
The overall market optimism helped by expectations that the Fed might start cutting interest rates in 2024 is helping riskier assets and equities, including small-cap stocks, penny stocks and cryptocurrencies...
Altimmune, Inc. (NASDAQ:ALT) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
5 Best Biotech Penny Stocks to Buy Now
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ranks 5th in our list of the best biotech penny stocks to buy now according to hedge funds. Ginkgo Bioworks Holdings, Inc.
Billionaire Hedge Funds
